Search Within

Joseph Manuel Gonzalez

  1. "Clifford Hudis"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (6)
  4. Survivorship Research (6)
  5. Biostatistics Service (4)
  6. Body Imaging Service (4)

More Groups

People
  1. Clifford Hudis (6)
  2. Tiffany Traina (5)
  3. Kimberly Feigin (4)
  4. Sujata Patil (4)
  5. Ayca Gucalp (3)
  6. Dilip Giri (3)

More People

Years
  1. 2013 (1)
  2. 2012 (4)
  3. 2011 (1)
Publications
  1. Cancer Research (2)
  2. Journal of Clinical Oncology (2)
  3. Breast Cancer Research and Treatment (1)
  4. Clinical Cancer Research (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (2)
  3. Springer (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase I/II study of a novel dose-dense schedule of oral indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Seidman, A.; Gajria, D.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
    Journal Article

    Gajria, D.; Gonzalez, J.; Feigin, K.; Patil, S.; Chen, C.; Theodoulou, M.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save